FALCO, Angela
 Distribuzione geografica
Continente #
NA - Nord America 1.474
EU - Europa 1.417
AS - Asia 873
SA - Sud America 127
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 3.909
Nazione #
US - Stati Uniti d'America 1.454
IT - Italia 402
CN - Cina 396
IE - Irlanda 260
SG - Singapore 242
SE - Svezia 237
FI - Finlandia 146
DE - Germania 127
BR - Brasile 120
HK - Hong Kong 97
FR - Francia 50
TR - Turchia 50
NL - Olanda 44
GB - Regno Unito 28
BE - Belgio 23
CZ - Repubblica Ceca 20
IN - India 20
AT - Austria 19
RU - Federazione Russa 19
VN - Vietnam 16
CA - Canada 15
BD - Bangladesh 14
LT - Lituania 10
CI - Costa d'Avorio 7
ID - Indonesia 7
ES - Italia 6
UA - Ucraina 6
JP - Giappone 5
PL - Polonia 5
RO - Romania 5
PK - Pakistan 4
UZ - Uzbekistan 4
AU - Australia 3
EU - Europa 3
JO - Giordania 3
MA - Marocco 3
AZ - Azerbaigian 2
CH - Svizzera 2
EC - Ecuador 2
GR - Grecia 2
IQ - Iraq 2
IR - Iran 2
MX - Messico 2
PS - Palestinian Territory 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BT - Bhutan 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MT - Malta 1
NI - Nicaragua 1
NP - Nepal 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 3.909
Città #
Chandler 308
Dublin 260
Singapore 165
Parma 163
Santa Clara 113
Ann Arbor 96
Hong Kong 94
Ashburn 87
Boardman 82
Shanghai 70
Dearborn 67
Nanjing 60
Beijing 58
Padova 57
Izmir 46
New York 46
Munich 45
Helsinki 39
Princeton 38
Bremen 33
Wilmington 29
Nanchang 23
Brussels 22
Hebei 17
Vienna 17
Los Angeles 15
Moscow 15
Dong Ket 14
Jinan 14
San Mateo 14
Seattle 13
Turku 13
Frankfurt am Main 12
Norwalk 12
Pune 12
Shenyang 12
Bologna 11
São Paulo 11
Woodbridge 11
Guangzhou 10
Hefei 10
Kunming 10
The Dalles 10
Brno 9
Council Bluffs 9
London 9
Rio Saliceto 9
Carpi 8
Changsha 8
Columbus 8
Dallas 8
Milan 8
Abidjan 7
Des Moines 7
Fremont 7
Jacksonville 7
Jiaxing 7
Marseille 7
Toronto 7
Jakarta 6
Nuremberg 6
Olomouc 6
Redwood City 6
Tianjin 6
Zhengzhou 6
Fuzhou 5
Hangzhou 5
Sector 6 5
Brasília 4
Edinburgh 4
Genova 4
Mirandola 4
Ningbo 4
Ottawa 4
Reggio Emilia 4
Rio de Janeiro 4
Tulsa 4
West Jordan 4
Amman 3
Borgonovo Val Tidone 3
Chicago 3
Contagem 3
Düsseldorf 3
Falkenstein 3
Haikou 3
Houston 3
Lorena 3
Modena 3
Salvador 3
São Bernardo do Campo 3
Taiyuan 3
Valleiry 3
Amsterdam 2
Ardea 2
Athens 2
Atlanta 2
Baku 2
Brooklyn 2
Campinas 2
Castro del Rio 2
Totale 2.528
Nome #
Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol 198
Subchronic exposure to titanium dioxide nanoparticles modifies cardiac structure and performance in spontaneously hypertensive rats 159
Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors 153
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 134
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism. 126
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 120
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 119
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method 116
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. 115
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 113
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation 111
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 111
Trimethylamine-N-Oxide (TMAO)-Induced Impairment of Cardiomyocyte Function and the Protective Role of Urolithin B-Glucuronide 109
Isolation and characterization of human lung lymphatic endothelial cells 107
A Hybrid In Silico/In Vitro Target Fishing Study to Mine Novel Targets of Urolithin A and B: A Step Towards a Better Comprehension of their Estrogenicity 102
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 102
Dissecting the cellular mechanisms of cardiotoxicity by anthracycline and tyrosine kinase inhibitors 101
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 101
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 100
In Vitro Biological and Functional Properties of Human Endothelial Cells from Different Sources Exposed to Different Beta-Blockers 99
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 97
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 96
Assessment of Cardiac Patches Suitability for Tissue Engineering 92
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 90
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 87
Bioactive Electrospun Fibers of Poly(glycerol sebacate) and Poly(ε-caprolactone) for Cardiac Patch Application 83
IMPACT OF THE TISSUE DISTRIBUTION OF SUBPOPULATIONS OF TILS AND PD-L1 EXPRESSION ON THE CLINICAL OUTCOME OF NSCLC 82
GCN5 contributes to intracellular lipid accumulation in human primary cardiac stromal cells from patients affected by Arrhythmogenic cardiomyopathy 81
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 80
LUNG MESENCHYMAL STEM CELLS FUNCTION AS THE INDUCTIVE MICROENVIRONMENT FOR HUMAN LUNG CANCER PROPAGATING CELLS 78
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 76
Differential Pattern of Myocardial Remodelling in Genetically Determined and Load- Dependent Hypertrophy in Humans 72
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 68
Development of biomimetic alginate/gelatin/elastin sponges with recognition properties toward bioactive peptides for cardiac tissue engineering 67
IGF-1 loaded injectable microspheres for potential repair of the infarcted myocardium 67
Correction: A versatile bioreactor for dynamic suspension cell culture. Application to the culture of cancer cell spheroids 65
Influence of injectable microparticle size on cardiac progenitor cell response 64
Reinforced alginate/gelatin sponges functionalized by avidin/biotin-binding strategy: a novel cardiac patch 61
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells 58
In vitro suspension bioreactor-based platform for culturing tumor cell clusters 56
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC 40
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 40
Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC 35
Totale 4.031
Categoria #
all - tutte 15.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.587


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 0 0 0 0 0 0 0 14
2020/2021220 10 7 9 7 43 24 10 23 35 9 19 24
2021/2022174 10 9 8 12 4 3 24 13 4 12 5 70
2022/20231.111 98 132 68 93 120 116 21 76 313 7 57 10
2023/2024453 18 36 8 17 48 100 36 21 14 38 58 59
2024/20251.093 25 50 82 91 131 94 72 62 126 97 114 149
Totale 4.031